Advisor Partners II’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$26.6M Buy
49,580
+759
+2% +$391K 1.07% 10
2023
Q2
$22.9M Buy
48,821
+3,335
+7% +$1.4M 1.07% 11
2023
Q1
$15.6M Buy
45,486
+373
+0.8% +$126K 0.86% 16
2022
Q4
$16.5M Buy
45,113
+3,011
+7% +$1.07M 1.02% 12
2022
Q3
$13.6M Buy
+42,102
New +$13.3M 1.03% 10

Other funds holding LLY

Advisor Partners II's LLY Position: Q3 2023 in Review

Advisor Partners II increased its Eli Lilly (LLY) stake by 1.6% in Q3 2023, buying an estimated $391K and bringing the position to 49,580 shares worth $26.6M. The position accounts for 1.07% of the portfolio, ranked #10.

Advisor Partners II first reported a position in LLY in Q3 2022 and has held it in 5 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • Advisor Partners II held 49,580 shares of Eli Lilly worth $26.6M as of Q3 2023.
  • Advisor Partners II bought 759 Eli Lilly shares in Q3 2023, an estimated $391K.
  • Eli Lilly made up 1.07% of Advisor Partners II's portfolio in Q3 2023, its #10 holding.
  • Advisor Partners II first reported a position in Eli Lilly in Q3 2022 and has held it in 5 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.